From: Quality of life utility values for hereditary haemochromatosis in Australia
HH-related comorbiditiesa | mean HSUV | SD | n |
---|---|---|---|
All participants | |||
 no comorbidity | 0.76 | 0.21 | 100 |
 arthritis | 0.52 | 0.25 | 35 |
 fibrosis | 0.53 | 0.29 | 7 |
 cirrhosis | 0.61 | 0.31 | 5 |
 heart failure | 0.58 | 0.24 | 3 |
 cardiomyopathy | 0.30 | - | 1 |
 diabetes | 0.52 | 0.33 | 4 |
 porphyria cutanea tarda | 0.02 | - | 1 |
Males | |||
 no comorbidity | 0.76 | 0.25 | 39 |
 arthritis | 0.59 | 0.23 | 15 |
 fibrosis | 0.69 | 0.05 | 5 |
 cirrhosis | 0.74 | 0.16 | 3 |
Females | |||
 no comorbidity | 0.76 | 0.19 | 61 |
 arthritis | 0.48 | 0.26 | 20 |
 fibrosis | 0.12 | 0.02 | 2 |
 cirrhosis | 0.42 | 0.45 | 2 |